Home Continuity Biosciences Launches First-in-Human Trial of IOP Precision Drug Delivery Platform for Pancreatic Cancer

Continuity Biosciences Launches First-in-Human Trial of IOP Precision Drug Delivery Platform for Pancreatic Cancer

May 20, 2026 19:57 CST Updated 20:24